Literature DB >> 19084527

Silencing efficiency differs among tissues and endogenous microRNA pathway is preserved in short hairpin RNA transgenic mice.

Hiroki Sasaguri1, Tasuku Mitani, Masayuki Anzai, Takayuki Kubodera, Yuki Saito, Hiromi Yamada, Hidehiro Mizusawa, Takanori Yokota.   

Abstract

In short hairpin RNA (shRNA) transgenic mice, the tissue difference in gene silencing efficiency and oversaturation of microRNA (miRNA) pathway have not been well assessed. We studied these problems in our previously-reported anti-copper/zinc superoxide dismutase (SOD1) shRNA transgenic mice. Although there was a tissue difference (liver and skeletal muscle, >95%; central nervous system and lung, approximately 80%), the target gene silencing was systemic and our anti-SOD1 shRNA transgenic mice recapitulated the SOD1-null mice. Neither endogenous miRNAs nor their target gene levels were altered, indicating the preservation of endogenous miRNA pathways. We think that the shRNA transgenic mice can be utilized for gene analysis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19084527     DOI: 10.1016/j.febslet.2008.12.012

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  3 in total

1.  Kinase/phosphatase overexpression reveals pathways regulating hippocampal neuron morphology.

Authors:  William J Buchser; Tatiana I Slepak; Omar Gutierrez-Arenas; John L Bixby; Vance P Lemmon
Journal:  Mol Syst Biol       Date:  2010-07       Impact factor: 11.429

Review 2.  Phenotypic screening with primary neurons to identify drug targets for regeneration and degeneration.

Authors:  Daniel J Cooper; Giulia Zunino; John L Bixby; Vance P Lemmon
Journal:  Mol Cell Neurosci       Date:  2016-07-18       Impact factor: 4.314

3.  A loss-of-function screen for phosphatases that regulate neurite outgrowth identifies PTPN12 as a negative regulator of TrkB tyrosine phosphorylation.

Authors:  Malene Ambjørn; Véronique Dubreuil; Federico Miozzo; Fabienne Nigon; Bente Møller; Shohreh Issazadeh-Navikas; Jacob Berg; Michael Lees; Jan Sap
Journal:  PLoS One       Date:  2013-06-13       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.